Analysis of the mechanism of action of Vigabatrin (Okeda) and its targets in the nervous system

Vigabatrin (Vigabatrin) is an irreversible inhibitor of γ-aminobutyric acid (GABA) aminotransferase. Its main mechanism of action is by inhibiting Prevent GABA degradation in neurons. GABA is one of the most important inhibitory neurotransmitters in the central nervous system. Increasing its concentration can enhance the inhibitory signals of neurons, thereby reducing abnormal discharges and nerve excitability. This mechanism gives Vigabatrin a unique advantage in the treatment of neurological diseases such as epilepsy, especially for refractory epilepsy and infantile spasms (infantile spasms).

In the target analysis of the nervous system, Vigabatrin mainly acts on neuronal areas related to GABA metabolism, such as the cerebral cortex, hippocampus and basal ganglia. These areas are closely related to the occurrence of epileptic seizures. By inhibiting GABAtransaminase, Vibatrin can increase the GABA concentration in these areas, enhance the hyperpolarization effect of postsynaptic neurons, inhibit abnormal neural discharges, thereby effectively reducing the frequency and intensity of epileptic seizures.

In addition, Vigabatrin has a certain degree of selectivity in its action. It mainly increases the level of GABA in neurons, but has less effect on excitatory neurotransmitters such as glutamate. This property allows it to enhance inhibitory neural signals without significantly interfering with normal neurological functions, thereby reducing the negative impact on cognitive and behavioral functions. In clinical application, Vibatrin is often used in combination with other anti-epileptic drugs to achieve synergy and improve efficacy.

It is worth noting that long-term use of Vigabatrin in the central nervous system requires attention to the risk of visual neurotoxicity. Long-term accumulation of high concentrations of GABA may cause certain damage to retinal nerve fibers, so patients need to undergo regular visual field examinations during medication. Through scientific monitoring, reasonable dosage and individualized medication, Vibatrin can exert its nervous system inhibitory effect while minimizing adverse reactions, providing a safe and effective treatment option for patients with epilepsy and related neurological diseases.

Reference link:https://www.drugs.com